| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +82 K | 100% | $2.24 | +$183 K |
| Sells | 0 | ||||
| Net | +2 | +82 K | 100% | +$183 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Wexford Capital Lp | 10%+ Owner | $7.93 M | Mar 13, 2024 | ||
| Arthur Amron | Director | $232 K | +$28.3 K | +13.9% | May 28, 2024 |
| Andrew Astor | President, CEO & CFO, Director | $204 K | Mar 5, 2022 | ||
| Oliver Spandow | Director | $200 K | May 14, 2024 | ||
| Robert R. Banks Jr. | President and CEO, Director | $157 K | +$155 K | +8529% | May 14, 2024 |
| Alisa Lask | Director | $119 K | May 14, 2024 | ||
| Tom Gwydir | Director | $95.2 K | Jan 5, 2023 | ||
| Wesley S. Lobo | Chief Marketing Officer | $77.5 K | Feb 16, 2022 | ||
| Joseph M. Harris | Director | $43.3 K | May 14, 2024 | ||
| Daron Evans | CEO Specialty Renal Products | $38.8 K | May 24, 2021 | ||
| Judy Krandel | Chief Financial Officer | Nov 1, 2023 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|